theraCUES is focused on the areas where molecular information/tests could make differences in therapeutics; and thereby help in better decision making for clinicians.
Cancer is one such therapeutic area where molecular tests can make immediate differences. Currently, we have necessary actionable probing technology for Oncology. In addition, we are working with key opinion leaders and other stake holders to bring decisive tests for other life threatening diseases.
theraCUES is open to collaborate with B2B partners to develop assays in our focus areas. theraCUES has proven technologies and capabilities to convert information to insights; and to develop impactful assays for probing DNA, RNA and Protein information, individually or altogether (3D assays).